BRIEF-Galaxy Biomedical Investment Sees 2019 Net Loss To Widen To 900-1,300 Mln Yuan

Jan 22 (Reuters) - Galaxy Biomedical Investment Co Ltd :

* SAYS IT SEES 2019 NET LOSS TO WIDEN TO 900-1,300 MILLION YUAN FROM 706.0 MILLION YUAN ($102.29 million) YEAR EARLIER Source text in Chinese: https://bit.ly/37iDYA4 Further company coverage: ($1 = 6.9018 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)